CoChat

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

Open access
Alcala, Nicolas, Mangiante, Lise, Le-Stang, Nolwenn, Gustafson, Corinne E., Boyault, Sandrine, Damiola, Francesca, Alcala, Karine, Brevet, Marie, Thivolet-Bejui, Françoise, Blanc-Fournier, Cécile, Le Rochais, Jean-Philippe, Planchard, Gaëtane, Rousseau, Nathalie, Damotte, Diane, Pairon, Jean Claude, Copin, Marie Christine, Scherpereel, Arnaud, Wasielewski, Eric, Wicquart, Laurence, Lacomme, Stéphanie, Vignaud, Jean-Michel, Ancelin, Gaspard, Girard, Cécile, Sagan, Christine, Bonnetaud, Christelle, Hofman, Véronique, Hofman, Paul, Mouroux, Jérôme, Thomas de Montpreville, Vincent, Clermont-Taranchon, Estelle, Mazieres, Julien, Rouquette, Isabelle, Begueret, Hugues, Blay, Jean-Yves, Lantuejoul, Sylvie, Bueno, Raphael, Caux, Christophe, Girard, Nicolas, McKay, James D., Foll, Matthieu, Galateau-Salle, Françoise, Fernandez-Cuesta, Lynnette · 2019 · EBioMedicine
Cited by 77

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Malignant Pleural Mesothelioma (MPM) is an aggressive disease related to asbestos exposure, with no effective therapeutic options. METHODS: We undertook unsupervised analyses of RNA-sequencing data of 284 MPMs, with no assumption of discreteness. Using immunohistochemistry, we performed an orthogonal validation on a subset of 103 samples and a biological replication in an independent series of 77 samples. FINDINGS: A continuum of molecular profiles explained the prognosis of the disease better than any discrete model. The immune and vascular pathways were the major sources of molecular variation, with strong differences in the expression of immune checkpoints and pro-angiogenic genes; the extrema of this continuum had specific molecular profiles: a "hot" bad-prognosis profile, with high lymphocyte infiltration and high expression of immune checkpoints and pro-angiogenic genes; a "cold" bad-prognosis profile, with low lymphocyte infiltration and high expression of pro-angiogenic genes; and a "VEGFR2+/VISTA+" better-prognosis profile, with high expression of immune checkpoint VISTA and pro-angiogenic gene VEGFR2. We validated the gene expression levels at the protein level for a subset of five selected genes belonging to the immune and vascular pathways (CD8A, PDL1, VEGFR3, VEGFR2, and VISTA), in the validation series, and replicated the molecular profiles as well as their prognostic value in the replication series. INTERPRETATION: The prognosis of MPM is best explained by a continuous model, which extremes show specific expression patterns of genes involved in angiogenesis and immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2019.09.003

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 77

Metadata

Authors
Alcala, N., Mangiante, L., Le-Stang, N., Gustafson, C. E., Boyault, S., Damiola, F., Alcala, K., Brevet, M., Thivolet-Bejui, F., Blanc-Fournier, C., Le Rochais, J.-P., Planchard, G., Rousseau, N., Damotte, D., Pairon, J. C., Copin, M. C., Scherpereel, A., Wasielewski, E., Wicquart, L., Lacomme, S., Vignaud, J.-M., Ancelin, G., Girard, C., Sagan, C., Bonnetaud, C., Hofman, V., Hofman, P., Mouroux, J., Thomas de Montpreville, V., Clermont-Taranchon, E., Mazieres, J., Rouquette, I., Begueret, H., Blay, J.-Y., Lantuejoul, S., Bueno, R., Caux, C., Girard, N., McKay, J. D., Foll, M., Galateau-Salle, F., & Fernandez-Cuesta, L.
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2019-10
Volume
48
Pages
191-202
ISSN
2352-3964 (ISSN-L)
OpenAlex
W2981442353
Cited by
77
References
16
FWCI
7.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions. https://app.cochat.ai/papers/10.1016/j.ebiom.2019.09.003
The paper
Alcala, N., Mangiante, L., Le-Stang, N., Gustafson, C. E., Boyault, S., Damiola, F., Alcala, K., Brevet, M., Thivolet-Bejui, F., Blanc-Fournier, C., Le Rochais, J.-P., Planchard, G., Rousseau, N., Damotte, D., Pairon, J. C., Copin, M. C., Scherpereel, A., Wasielewski, E., Wicquart, L., . . . Fernandez-Cuesta, L. (2019). Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions. EBioMedicine. https://doi.org/10.1016/j.ebiom.2019.09.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.